Rarity Bioscience
PrivateLast Round
VC Round
Jun 18, 2024
Total Funding Raised
$3.22M
Momentum Score
50 /100
Company Overview
Rarity Bioscience is a biotechnology company that provides ultra-sensitive multiplex assays for mutation detection in liquid biopsies for research and clinical applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Rarity Bioscience Comps
Public and private peers based on sector, stage, and business model.
Rarity Bioscience Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 18, 2024 | ||||
| Seed | Feb 6, 2023 | ||||
| Seed | Jul 12, 2021 |
Key People
Founding team and executive leadership
Rarity Bioscience Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Navigare Ventures | Seed, VC Round |
| Novalis Biotech | Seed, VC Round |
Rarity Bioscience Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Rarity Bioscience's valuation, stock price, and market status.
